329 related articles for article (PubMed ID: 23383076)
1. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials.
Sun Z; Fu Q; Cao L; Jin W; Cheng L; Li Z
PLoS One; 2013; 8(1):e55124. PubMed ID: 23383076
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Zagler A; Azadpour M; Mercado C; Hennekens CH
Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of the impact of N-acetylcysteine on contrast nephropathy.
Pannu N; Manns B; Lee H; Tonelli M
Kidney Int; 2004 Apr; 65(4):1366-74. PubMed ID: 15086476
[TBL] [Abstract][Full Text] [Related]
4. Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Bagshaw SM; Ghali WA
Arch Intern Med; 2005 May; 165(10):1087-93. PubMed ID: 15911721
[TBL] [Abstract][Full Text] [Related]
5. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.
Nallamothu BK; Shojania KG; Saint S; Hofer TP; Humes HD; Moscucci M; Bates ER
Am J Med; 2004 Dec; 117(12):938-47. PubMed ID: 15629733
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.
Kang X; Hu DY; Li CB; Ai ZS; Peng A
Ren Fail; 2015 Nov; 37(10):297-303. PubMed ID: 26458505
[TBL] [Abstract][Full Text] [Related]
7. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
Zoungas S; Ninomiya T; Huxley R; Cass A; Jardine M; Gallagher M; Patel A; Vasheghani-Farahani A; Sadigh G; Perkovic V
Ann Intern Med; 2009 Nov; 151(9):631-8. PubMed ID: 19884624
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis.
Feng Y; Huang X; Li L; Chen Z
Nephrology (Carlton); 2018 Jun; 23(6):530-538. PubMed ID: 28452187
[TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
Gawenda M; Möller A; Wassmer G; Brunkwall J
Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
[TBL] [Abstract][Full Text] [Related]
11. Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.
Li JX; Jin EZ; Yu LH; Li Y; Liu NN; Dong YM; Li X; Li XQ
Exp Ther Med; 2017 Aug; 14(2):1568-1576. PubMed ID: 28810622
[TBL] [Abstract][Full Text] [Related]
12. Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty.
Aslanger E; Uslu B; Akdeniz C; Polat N; Cizgici Y; Oflaz H
Coron Artery Dis; 2012 Jun; 23(4):265-70. PubMed ID: 22343798
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes.
Jaffery Z; Verma A; White CJ; Grant AG; Collins TJ; Grise MA; Jenkins JS; McMullan PW; Patel RA; Reilly JP; Thornton SN; Ramee SR
Catheter Cardiovasc Interv; 2012 May; 79(6):921-6. PubMed ID: 21542122
[TBL] [Abstract][Full Text] [Related]
14. Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department.
Kama A; Yılmaz S; Yaka E; Dervişoğlu E; Doğan NÖ; Erimşah E; Pekdemir M
Acad Emerg Med; 2014 Jun; 21(6):615-22. PubMed ID: 25039544
[TBL] [Abstract][Full Text] [Related]
15. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Navaneethan SD; Singh S; Appasamy S; Wing RE; Sehgal AR
Am J Kidney Dis; 2009 Apr; 53(4):617-27. PubMed ID: 19027212
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.
Wu MY; Hsiang HF; Wong CS; Yao MS; Li YW; Hsiang CY; Bai CH; Hsu YH; Lin YF; Tam KW
Int Urol Nephrol; 2013 Oct; 45(5):1309-18. PubMed ID: 23283594
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Zhao SJ; Zhong ZS; Qi GX; Tian W
Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.
Webb JG; Pate GE; Humphries KH; Buller CE; Shalansky S; Al Shamari A; Sutander A; Williams T; Fox RS; Levin A
Am Heart J; 2004 Sep; 148(3):422-9. PubMed ID: 15389228
[TBL] [Abstract][Full Text] [Related]
19. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
Brown JR; Block CA; Malenka DJ; O'Connor GT; Schoolwerth AC; Thompson CA
JACC Cardiovasc Interv; 2009 Nov; 2(11):1116-24. PubMed ID: 19926054
[TBL] [Abstract][Full Text] [Related]
20. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
